SCHEMBL6496972

SCHEMBL6496972

Cc1cccc(C)c1NC(=O)CN1C[C@@H](C)N(c2ncc3ccsc3n2)[C@@H](C)C1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.41
KMT2A Q03164 4/20 0.39
LMNA P02545 3/20 0.39
POLB P06746 1/20 0.39
KCNA5 P22460 1/20 0.38
DRD4 P21917 4/20 0.38
CYP3A4 P08684 3/20 0.37
MEN1 O00255 2/20 0.37
CYP2D6 P10635 2/20 0.37
MLNR O43193 1/20 0.37
NR1I2 O75469 1/20 0.37
USP2 O75604 1/20 0.37
CYP1A2 P05177 1/20 0.37
PGR P06401 1/20 0.37
ADRB1 P08588 1/20 0.37
ADRA2A P08913 1/20 0.37
ADORA3 P0DMS8 1/20 0.37
CYP2C9 P11712 1/20 0.37
DRD2 P14416 1/20 0.37
ADRA2B P18089 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6496976 1.00 ALDH1A1 (0.41) ALDH1A1KMT2ALMNAPOLBKCNA5
SCHEMBL6498620 0.80 KCNA5 (0.41) ALDH1A1KMT2ALMNAPOLBKCNA5
SCHEMBL6498617 0.80 KCNA5 (0.41) ALDH1A1KMT2ALMNAPOLBKCNA5
SCHEMBL6342770 0.79 ALDH1A1 (0.41) ALDH1A1KMT2ALMNAPOLBKCNA5
SCHEMBL6342765 0.79 ALDH1A1 (0.41) ALDH1A1KMT2ALMNAPOLBKCNA5
SCHEMBL6500012 0.78 MEN1 (0.39) KMT2ALMNAMEN1DRD2HTR2A
SCHEMBL6334608 0.73 LMNA (0.42) ALDH1A1KMT2ALMNAKCNA5DRD4
SCHEMBL6492609 0.69 ABL1 (0.36) ALDH1A1DRD4
SCHEMBL6332759 0.69 MEN1 (0.44) ALDH1A1KMT2ALMNAPOLBCYP3A4
SCHEMBL6332762 0.69 MEN1 (0.44) ALDH1A1KMT2ALMNAPOLBCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050272745-A1 Novel piperidine and piperazine derivatives ASTRAZENECA AB 2005-12-08 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050272745-A1 Novel piperidine and piperazine derivatives CYP3A5, IL5, ABCC5 ALDH1A1 187/4885KMT2A 2331/4885LMNA 3565/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.